A Study of Cerebral Perfusion with TDCS in Chronic Hypoperfusion

NAEnrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 24, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Moyamoya SyndromeMoyamoya DiseaseAtheroscleroses, Cerebral
Interventions
DEVICE

Soterix® 4x1HD-TDCS

Is intended for inducing cortical neuromodulation for research and treatment purposes.

DEVICE

Soterix® 1x1 tDCS

At-home remotely supervised transcranial direct current stimulation (tDCS) at an intensity of 2 mA for 20 minutes per session, with slow ramp-up and automatic turn off once it reaches the maximal intensity.

BEHAVIORAL

Cognitive training program

Computerized cognitive therapy for 45 minutes per day that starts at the same time with stimulation

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER